Indaptus Therapeutics Inc. - Common Stock, $0.01 par value (INDP)

CUSIP: 45339J105

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
113,265,306
Total 13F shares
566,356
Share change
+66,011
Total reported value
$1,222,000
Price per share
$2.17
Number of holders
12
Value change
+$141,749
Number of buys
6
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 45339J105?
CUSIP 45339J105 identifies INDP - Indaptus Therapeutics Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Indaptus Therapeutics Inc. - Common Stock, $0.01 par value (INDP) as of Q3 2022

As of 30 Sep 2022, Indaptus Therapeutics Inc. - Common Stock, $0.01 par value (INDP) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 566,356 shares. The largest 10 holders included VANGUARD GROUP INC, INVESTMENT HOUSE LLC, STRATEGY ASSET MANAGERS LLC, GEODE CAPITAL MANAGEMENT, LLC, Stratos Wealth Partners, LTD., Vivaldi Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, NORTHERN TRUST CORP, and CITADEL ADVISORS LLC. This page lists 12 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.